Hyperlipidaemic effect of fish oil in Bio F1B hamsters.
We investigated the dietary influence of low and high levels of fish oil, supplemented with or without dietary cholesterol, on the plasma lipoprotein profile in Bio F1B hamsters, a model susceptible to diet-induced hyperlipidaemia. The MIX diet, a diet supplemented with a mixture of lard and safflower-seed oil, was used as the control diet to maintain the saturated MUFA and PUFA levels similar to the fish-oil diet. The animals were fed the specific diets for 2 weeks and fasted for 14 h before killing. The plasma from the animals fed high levels of fish oil was milky and rich in chylomicron-like particles. The plasma total cholesterol, VLDL- and LDL-cholesterol and -triacylglycerol concentrations were significantly higher, whereas HDL-cholesterol was lower in hamsters fed fish oil compared with the MIX-diet-fed hamsters. Increasing the amount of fat in the diet increased plasma lipids in both the fish-oil- and the MIX-diet-fed hamsters; however, this hyperlipidaemic effect of dietary fat level was greater in the hamsters fed the fish-oil diet. The hepatic lipid concentrations were not dramatically different between the fish-oil-fed and the MIX-diet-fed hamsters. However, the hepatic LDL-receptor mRNA levels were significantly low in the fish-oil-fed hamsters compared with the MIX-diet-fed hamsters. Increasing the amount of fish oil in the diet further decreased the hepatic LDL-receptor mRNA expression. It is concluded that F1B hamsters are susceptible to fish-oil-induced hyperlipidaemia, especially at high fat levels, and this increase is partially explained by the inhibition of hepatic LDL-receptor mRNA expression.
Department of Biochemistry, Memorial University of Newfoundland, St John's, NL, Canada A1B 3X9.
Pujitha P
PP
de Silva
Phillip J
PJ
Davis
Sukhinder Kaur
SK
Cheema
D000818:Animals; D002791:Cholesterol, Dietary / Q000008:administration & dosage; D002914:Chylomicrons / Q000032:analysis; D006224:Cricetinae; D004041:Dietary Fats / Q000008:administration & dosage; D004198:Disease Susceptibility; D005395:Fish Oils / Q000008:administration & dosage / Q000009:adverse effects*; D005786:Gene Expression Regulation / Q000187:drug effects; D006949:Hyperlipidemias / Q000097:blood / Q000139:chemically induced*; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008099:Liver / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics; D011973:Receptors, LDL / Q000096:biosynthesis / Q000235:genetics
D002791:Cholesterol, Dietary; D002914:Chylomicrons; D004041:Dietary Fats; D005395:Fish Oils; D008055:Lipids; D008074:Lipoproteins; D012333:RNA, Messenger; D011973:Receptors, LDL